Review
doi: 10.1055/s-0028-1110470.
[Treatment of multiple myeloma with a new cytostatic agent: gamma-l-methyl-5-bis-(beta-chlorethyl)-amino-benzimidazolyl-(2)-butyric acid hydrochloride]
[Article in
German]
- PMID: 4903552
- DOI: 10.1055/s-0028-1110470
Item in Clipboard
Review
[Treatment of multiple myeloma with a new cytostatic agent: gamma-l-methyl-5-bis-(beta-chlorethyl)-amino-benzimidazolyl-(2)-butyric acid hydrochloride]
[Article in
German]
Dtsch Med Wochenschr.
.
No abstract available
Similar articles
-
Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).Acta Pol Pharm. 2002 Nov-Dec;59(6):478-82. Acta Pol Pharm. 2002. PMID: 12669777 Clinical Trial.
-
Therapy of macroglobulinaemia. Comparison of the effect of therapy on the level of monoclonal immunoglobulins and on clinical symptoms in four cases of waldenström's macroglobulinaemia and one case of IgA myeloma.Acta Med Scand. 1969 Oct;186(4):273-81. Acta Med Scand. 1969. PMID: 4190857 Clinical Trial. No abstract available.
-
Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma.Br J Haematol. 2010 Dec;151(5):530-1. doi: 10.1111/j.1365-2141.2010.08388.x. Epub 2010 Sep 29. Br J Haematol. 2010. PMID: 20880117 No abstract available.
-
Clinical trial designs for multiple myeloma.Clin Adv Hematol Oncol. 2007 Apr;5(4):309-16. Clin Adv Hematol Oncol. 2007. PMID: 17607290 Review.
-
[Recent progress in chemotherapy of multiple myeloma].Recenti Prog Med. 1978 Jul;65(1):44-68. Recenti Prog Med. 1978. PMID: 370935 Review. Italian. No abstract available.
Cited by
-
Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block.Clin Cancer Res. 2009 Dec 15;15(24):7456-7461. doi: 10.1158/1078-0432.CCR-08-3041. Clin Cancer Res. 2009. PMID: 19996200 Free PMC article. No abstract available.
-
Novel Agents in Multiple Myeloma.Cancer J. 2019 Jan/Feb;25(1):45-53. doi: 10.1097/PPO.0000000000000355. Cancer J. 2019. PMID: 30694859 Free PMC article. Review.
-
Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin's lymphoma.Ther Clin Risk Manag. 2008 Aug;4(4):727-32. doi: 10.2147/tcrm.s3158. Ther Clin Risk Manag. 2008. PMID: 19209254 Free PMC article.
-
Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone--a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO).J Cancer Res Clin Oncol. 2006 Apr;132(4):205-12. doi: 10.1007/s00432-005-0074-4. Epub 2006 Jan 10. J Cancer Res Clin Oncol. 2006. PMID: 16402269 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
